Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fragmin (dalteparin) in pregnant women with prior uteroplacental insufficiency and thrombophilia
2005-005850-30Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of dalteparin in preeclampsia, intrauterine growth restriction (IUGR), placental insufficiency and 1 more (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Recurrence of pre-eclampsia and Recurrence of small-for-gestational-age infants. Started Jan 2006; status: completed.
02
Drugs
dalteparin
03
Conditions
preeclampsiaintrauterine growth restriction (IUGR)placental insufficiencyHypercoagulability
Beyond the preview
Go deeper on 2005-005850-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005850-30.